NNVC Ships Monkeypox Treatment
NanoViricides ships NV-387 oral gummies to the Democratic Republic of Congo for its Phase II clinical trial of monkeypox treatment
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.